Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
101 (47%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-PROGESTERONE | 100MG | CAPSULE | Resolved | 2020-12-17 | 2021-02-11 | 130288 |
| TEVA-PROGESTERONE | 100MG | CAPSULE | Resolved | 2021-01-28 | 2021-03-18 | 132633 |
| TEVA-PROGESTERONE | 100MG | CAPSULE | Resolved | 2021-05-20 | 2021-07-09 | 139740 |
| TEVA-PROGESTERONE | 100MG | CAPSULE | Resolved | 2017-08-02 | 2017-10-10 | 17983 |
| TEVA-PROPOFOL | 10MG | EMULSION | Actual shortage | 2020-04-10 | 2020-05-14 | 111871 |
| TEVA-PROPOFOL | 10MG | EMULSION | Actual shortage | 2020-07-30 | 2020-07-30 | 121494 |
| TEVA-PROPRANOLOL | 10MG | TABLET | Resolved | 2020-06-25 | 2020-07-23 | 118945 |
| TEVA-PROPRANOLOL | 80MG | TABLET | Resolved | 2020-04-03 | 2020-09-03 | 110764 |
| TEVA-PROPRANOLOL | 10MG | TABLET | Resolved | 2020-04-10 | 2020-04-16 | 111819 |
| TEVA-PROPRANOLOL | 40MG | TABLET | Resolved | 2020-04-10 | 2020-05-21 | 111835 |
| TEVA-PROPRANOLOL | 80MG | TABLET | Resolved | 2020-05-01 | 2020-05-14 | 113741 |
| TEVA-PROPRANOLOL | 10MG | TABLET | Resolved | 2020-05-29 | 2020-07-23 | 116147 |
| TEVA-PROPRANOLOL | 20MG | TABLET | Resolved | 2017-08-02 | 2021-10-14 | 17976 |
| TEVA-PROPRANOLOL | 20MG | TABLET | Resolved | 2017-08-02 | 2021-10-14 | 17979 |
| TEVA-PROPRANOLOL | 40MG | TABLET | Resolved | 2018-03-16 | 2018-05-30 | 43126 |
| TEVA-PROPRANOLOL | 40MG | TABLET | Resolved | 2022-12-15 | 2023-07-06 | 178530 |
| TEVA-PROPRANOLOL | 80MG | TABLET | Resolved | 2023-01-19 | 2023-04-28 | 181623 |
| TEVA-PROPRANOLOL | 10MG | TABLET | Resolved | 2023-02-09 | 2023-07-12 | 184177 |
| TEVA-PROPRANOLOL | 40MG | TABLET | Resolved | 2023-02-09 | 2023-07-12 | 184180 |
| TEVA-PROPRANOLOL | 20MG | TABLET | Resolved | 2023-02-16 | 2023-07-06 | 184949 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| METHOTREXATE SODIUM INJECTION | 25MG | SOLUTION | Discontinued | 2025-04-25 | 2025-04-25 | 255818 |
| METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION | 40MG | POWDER FOR SOLUTION | Discontinued | 2021-09-23 | 2021-09-23 | 146061 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-04-11 | 2019-04-11 | 81321 |
| NOVAMOXIN | 500MG | CAPSULE | Discontinued | 2017-06-27 | 2017-06-27 | 14046 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81316 |
| NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
| NOVAMOXIN | 25MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81393 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-10-25 | 2019-10-26 | 97251 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
| NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
| NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
| NOVO-PROFEN | 200MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81310 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 |